Womens health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications, announced the closing of a $19.3M financing led by InterWest, Domain Associates and Catalyst Health Ventures. Also participating in the round are the company's founder, UpStart Life Sciences Capital, and new investor Osage University Partners.
Read More